A VA researcher will investigate the effects of discontinuing thyroid replacement therapy in patients with subclinical hypothyroidism. It may pave the way to address levothyroxine overuse by Veterans.
Research plays a critical role in the treatment of Veterans. The VA Center for the Prevention and Treatment of Visual Loss is part of that role.
This year, National VA Research Week, May 11–15, focuses on "Empowering Veterans Through Research." Since 1925, VA researchers have been discovering new ways to treat disease and improve Veterans' health. VA has a proud history of conducting high-quality clinical trials that benefit the nation. That mission is especially relevant during the COVID-19 pandemic.
VA research study aims to establish a stronger sense of social connectedness for Veterans at high risk of suicide by increasing their participation in community activities.
In this episode you are introduced to the hosts of the Vets First Podcast, Levi Sowers and Brandon Rea. They discuss the podcast and goals surrounding it.
Dr. Mark Logue, an Army Veteran, is a statistician in the National Center for PTSD at the VA Boston Healthcare System. His research interests include the genetics of brain disorders such as PTSD, Alzheimer’s disease, and anxiety.
VA researchers are studying GERD, a digestive disorder that affects the lower esophageal valve that controls the flow between the esophagus and stomach.
It’s the first method in the world that can activate muscles – using minimally invasive techniques – to produce an effective cough. Veteran: "This research…is helping to improve the lives of others."
Four U.S. Department of Veterans Affairs (VA) researchers will receive the Presidential Early Career Award for Scientists and Engineers (PECASE).
VA researchers showcased their latest scientific, medical, and technological advances at the second annual “VA Research Day on the Hill.”
Scientists at the Southeast Louisiana Veterans Health Care System and Tulane University have announced a breakthrough in research that could lead to safer treatment of pain with less risk for addiction and overdose compared to currently available opioid medications.
APOLLO is a complex acronym for a data collection project with an important goal: individualized cancer treatment. VA is working with federal partners in largely unprecedented cancer research.












